Literature DB >> 32812345

Usefulness of the Edmonton Obesity Staging System for stratifying the presence and severity of weight-related health problems in clinical and community settings: A rapid review of observational studies.

Evan Atlantis1,2, Mehdi Sahebolamri1,3, Birinder S Cheema4, Kathryn Williams3,5.   

Abstract

This rapid review aimed to examine the usefulness of the Edmonton Obesity Staging System (EOSS) for stratifying the presence and severity of weight-related health problems in clinical and community settings. We searched PubMed, CINAHL and ProQuest for records from 2009 to May 2020. We considered observational studies in participants with overweight or obesity that investigated the risk of any clinical outcome associated with increasing EOSS. We reviewed and appraised 20 observational studies (cohort = 4, case series = 7, cross-sectional = 9) published between 2011 and 2020. Of 12 studies in clinical populations, the EOSS was most consistently associated with an increased risk of postoperative complications following bariatric surgery, especially for EOSS 3-4, and inversely associated with weight loss, treatment time and resolution of hypertension following bariatric surgery and clinical weight management. Of eight studies in community populations, the EOSS most consistently predicted mortality outcomes, especially for EOSS 3, and was associated with polypharmacy, service use and poorer work outcomes. Studies reported diverse EOSS definitions and outcomes, which slightly weakens the overall evidence base. The EOSS should be routinely used for predicting risks and benefits of surgical and nonsurgical weight management, but it should be applied with caution for population health planning.
© 2020 World Obesity Federation.

Entities:  

Keywords:  BMI; EOSS; overweight; prognosis

Year:  2020        PMID: 32812345     DOI: 10.1111/obr.13120

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  9 in total

1.  Development and internal validation of the Edmonton Obesity Staging System-2 Risk screening Tool (EOSS-2 Risk Tool) for weight-related health complications: a case-control study in a representative sample of Australian adults with overweight and obesity.

Authors:  Evan Atlantis; James Rufus John; S L Hocking; Kath Peters; Kathryn Williams; Paul Dugdale; P Fahey
Journal:  BMJ Open       Date:  2022-06-22       Impact factor: 3.006

2.  Periodontal and systemic health of morbidly obese patients eligible for bariatric surgery: a cross-sectional study.

Authors:  Dejana Čolak; Alja Cmok Kučič; Tadeja Pintar; Boris Gašpirc; Rok Gašperšič
Journal:  BMC Oral Health       Date:  2022-05-13       Impact factor: 3.747

3.  Clinical usefulness of brief screening tool for activating weight management discussions in primary cARE (AWARE): A nationwide mixed methods pilot study.

Authors:  Evan Atlantis; James Rufus John; Paul Patrick Fahey; Samantha Hocking; Kath Peters
Journal:  PLoS One       Date:  2021-10-28       Impact factor: 3.240

4.  Clinical Use of the Edmonton Obesity Staging System for the Assessment of Weight Management Outcomes in People with Class 3 Obesity.

Authors:  Raymond Kodsi; Ritesh Chimoriya; David Medveczky; Kathy Grudzinskas; Evan Atlantis; Abd A Tahrani; Nic Kormas; Milan K Piya
Journal:  Nutrients       Date:  2022-02-24       Impact factor: 5.717

5.  Obesity and Bariatric Surgery in Australia: Future Projection of Supply and Demand, and Costs.

Authors:  Sithara Wanni Arachchige Dona; Mary Rose Angeles; Dieu Nguyen; Lan Gao; Martin Hensher
Journal:  Obes Surg       Date:  2022-07-08       Impact factor: 3.479

6.  The Association of Physical Function Measures With Frailty, Falls History, and Metabolic Syndrome in a Population With Complex Obesity.

Authors:  Amanda Rhynehart; Colin Dunlevy; Katie Hayes; Jean O'Connell; Donal O'Shea; Emer O'Malley
Journal:  Front Rehabil Sci       Date:  2021-09-16

7.  The Edmonton Obesity Staging System and pregnancy outcomes in women with overweight or obesity: A secondary analysis of a randomized controlled trial.

Authors:  Sarah Louise Killeen; Cara A Yelverton; Aisling A Geraghty; Maria A Kennelly; Shane Eakins; Lily Farrell; Jillian F Fagan; John Mehegan; Fionnuala M McAuliffe
Journal:  Clin Obes       Date:  2022-02-24

8.  Higher Inflammation Is Associated with Cardiometabolic Phenotype and Biochemical Health in Women with Obesity.

Authors:  Sarah Louise Killeen; David F Byrne; Aisling A Geraghty; Mark T Kilbane; Patrick J Twomey; Malachi J McKenna; Cara A Yelverton; Radka Saldova; Douwe Van Sinderen; Paul D Cotter; Eileen F Murphy; Fionnuala M McAuliffe
Journal:  Ann Nutr Metab       Date:  2022-03-18       Impact factor: 5.923

9.  Using the Edmonton Obesity Staging System in the real world: a feasibility study based on cross-sectional data.

Authors:  Rukia Swaleh; Taylor McGuckin; Tyler W Myroniuk; Donna Manca; Karen Lee; Arya M Sharma; Denise Campbell-Scherer; Roseanne O Yeung
Journal:  CMAJ Open       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.